TREA

Novel class of compounds (Choline derivatives, esp. Stearyl Choline Cloride and other salts) for the treatment of Alzheimer's disease, Down syndrome and central (and/or peripheral) nervous system and memory related disorders or for enhancements

Follow

Information

  • Patent Application
  • 20050038116
  • Publication Number
    20050038116
  • Date Filed
    August 15, 2003
    21 years ago
  • Date Published
    February 17, 2005
    19 years ago
Information
Abstract
This invention is for the treatment of Alzheimer's disease, Down syndrome, Central (or Peripheral) Nervous Systems' disorders or for the enhancement of memory and central nervous system or peripheral nervous system. In this invention a novel class of Choline derivatives are recommended for the above mentioned indications. These derivatives are the esters of Choline. An example of this class was newly synthesized using Stearic acid. This derivative named Stearyl Choline Cloride or Choline Staearate Chloride or Stearic acid ester of Choline was synthesized and tested in animals. The results are positive.
Description
BACKGROUND OF THE INVENTION

The invention is centered on the use of the Choline derivatives (esters) which are sufficiently hydrophobic to cross the blood brain barrier. The ester moiety can be any chemical group. Thus these esters can be used for the following purposes: The use of the class of compounds described in claim 1 for the treatment of the following:

    • Alzheimer's disease
    • Down syndrome
    • Central Nervous System (CNS) disorders
    • Peripheral Nervous System (PNS) disorders
    • Memory related disorders
    • Enhancements of memory and related function
    • Enhancement of CNS functions
    • Enhancements of PNS functions
    • Improvement of cognition
    • Improvement in learning and behavior


This invention is for the treatment of Alzheimer's disease, Down syndrome, Central (or Peripheral) Nervous Systems' disorders or for the enhancement of memory and central nervous system or peripheral nervous system. In this invention a novel class of Choline derivatives (See Table 1 and Table 2) are recommended for the above mentioned indications. These derivatives are the esters of Choline. An example of this class was newly synthesized using Stearic acid. This derivative named Stearyl Choline Cloride or Choline Staearate Chloride or Stearic acid ester of Choline was synthesized and tested in animals.


Use of the these Choline ester derivatives will allow the followings:






    • 1. Will help treat Alzheimer's disease.

    • 2. Will help improve memory functions and Central nervous System and/or Peripheral Nervous System disorders.

    • 3. Will help the treatment of Down Syndrome.





BRIEF SUMMARY OF THE INVENTION

The current invention is centered on the use synthesis and use of Choline esters (see Table 1) (esp. Stearyl Choline Salts) for the treatment of the following indications:

    • a. Alzheimer's disease
    • b. Down syndrome
    • c. Central Nervous System (CNS) disorders
    • d. Peripheral Nervous System (PNS) disorders
    • e. Memory related disorders
    • f. Enhancements of memory and related function
    • g. Enhancement of CNS functions
    • h. Enhancements of PNS functions
    • i. Improvement of cognition
    • j. Improvement in learning and behavior


Following are the claimed benefits of the use Choline esters (esp. Stearyl Choline Salt):

    • 1. Better absorption through the GI system
    • 2. Better penetration through the blood brain barrier.
    • 3. No toxicity as it is made up of natural compounds
    • 4. No side effects







DETAILED DESCRIPTION OF THE INVENTION

This invention is for the treatment of Alzheimer's disease, Down syndrome, Central (or Peripheral) Nervous Systems' disorders or for the enhancement of memory and central nervous system or peripheral nervous system. In this invention a novel class of Choline derivatives are recommended for the above mentioned indications. These derivatives are the esters of Choline. An example of this class was newly synthesized using Stearic acid. This derivative named Stearyl Choline Cloride or Choline Staearate Chloride or Stearic acid ester of Choline was synthesized and tested in animals.


Use of the these Choline ester derivatives will allow the followings:






    • Will help treat Alzheimer's disease.

    • Will help improve memory functions and

    • Will help the treatment of Down Syndrome.

    • In treatment of Central Nervous System (CNS) disorders

    • In treatment of Peripheral Nervous System (PNS) disorders

    • Help in treating memory related disorders

    • Will help in enhancements of memory and related function

    • Will help in enhancement of CNS functions

    • Will help in enhancements of PNS functions

    • Will help in improvement of cognition

    • Will help in improvement in learning and behavior


      Other benefits of the use of Choline esters are:

    • Better absorption through the GI system

    • Better penetration through the blood brain barrier.

    • No toxicity as it is made up of natural compounds





No side effects

TABLE 1Structures of Choline Estersembedded imageR = —(CH2)17—CH3 =stearyl cholinechloride or choinestearate chlorideR =Any other chemicalmoiety

embedded image

Claims
  • 1. Invention of Choline ester derivatives including Stearyl Choline Chloride (other names Choline Stearate Chloride, Choline ester of Stearic acid) are claimed for the treatment of the indications listed in claim 3.
  • 2. Stearyl Choline Salts or Choline Stearate Chloride or other salts is claimed as novel compounds for the treatments claimed in claim 3.
  • 3. The use of the class of compounds described in claim 1 and 2 for the treatment of the following: Alzheimer's disease Down syndrome Central Nervous System (CNS) disorders Peripheral Nervous System (PNS) disorders Memory-related disorders Enhancements of memory and related function Enhancement of CNS functions Enhancements of PNS functions Improvement of cognition Improvement in learning and behavior